Funding for this research was provided by:
Skåne University Hospital donation funds
Alfred Österlund Foundation
City of Malmö, the Swedish Medical Research Council
Swedish Heart and Lung Foundation
Received: 17 April 2020
Accepted: 2 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: The Regional Ethics Committee at Lund University (Dnr 85/2004) granted ethical approval for this study.
: Not applicable
: TF and MCK declare no competing interests. PMN declares modest honoraria for lecturing from Merck, AstraZeneca, Boehringer, and Novo Nordisk. CT has received consulting fees from Roche; speaking fees from Abbvie, Bristol Myers-Squibb, Pfizer, and Roche; and an unrestricted research grant from Bristol Myers-Squibb. MD has received consulting fees from Grünental. ND declares personal fees (all < $10,000) from Hengrui, Selecta, Arthrosi, AstraZeneca, Horizon, Dyve Biosciences, Abbvie, and Janssen. LTHJ has received lecture and consulting fees from Pfizer, Abbvie, Novartis, and Eli-Lily.